This contribution explores the underuse of artificial intelligence (AI) in the health sector, what this means for practice, and how much the underuse can cost. Attention is drawn to the relevance of an issue that the European Parliament has outlined as a "major threat" in 2020. At its heart is the risk that research and development on trusted AI systems for medicine and digital health will pile up in lab centers without generating further practical relevance. Our analysis highlights why researchers, practitioners and especially policymakers, should pay attention to this phenomenon.

The underuse of AI in the health sector: Opportunity costs, success stories, risks and recommendations

Ugo Pagallo
;
2024-01-01

Abstract

This contribution explores the underuse of artificial intelligence (AI) in the health sector, what this means for practice, and how much the underuse can cost. Attention is drawn to the relevance of an issue that the European Parliament has outlined as a "major threat" in 2020. At its heart is the risk that research and development on trusted AI systems for medicine and digital health will pile up in lab centers without generating further practical relevance. Our analysis highlights why researchers, practitioners and especially policymakers, should pay attention to this phenomenon.
2024
14
1
14
Ugo Pagallo, Shane O’Sullivan, Nathalie Nevejans, Andreas Holzinger, Michael Friebe, Fleur Jeanquartier, Claire Jean-Quartier & Arkadiusz Miernik...espandi
File in questo prodotto:
File Dimensione Formato  
Health & Technology (Pagallo et al. 2024).pdf

Accesso aperto

Dimensione 578.68 kB
Formato Adobe PDF
578.68 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/2030399
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 44
  • ???jsp.display-item.citation.isi??? 38
social impact